Javascript must be enabled to continue!
Abstract 112: Statin Utilization in the Outpatient Clinic of a University Based Residency Training Program
View through CrossRef
Background:
Current guidelines released in 2013 recommend statins for five specific patient groups including persons with clinical atherosclerotic cardiovascular disease (ASCVD) and diabetes. National estimates of statin utilization in 2012 report statin use in persons with ASCVD at 58.8% and 63.5% among persons with diabetes. A recent review also showed suboptimal statin prescription rates prior to 2013, with only 23% being prescribed a statin at goal dose. Our goal was to assess statin prescriptions in a large resident run outpatient clinic and identify factors affecting statin prescriptions as potential targets for intervention to improve compliance with the guidelines.
Methods:
We obtained data from the medical record data warehouse of a primary care outpatient clinic within a large safety-net hospital from Jan–Dec 2015. The clinic is predominantly run by internal medicine residents and supervised by general internal medicine attending physicians. Patients with a diagnosis of ASCVD and diabetes were identified and electronic medical records abstraction was done to identify persons who were prescribed a statin (regardless of dose). Bivariate analyses were conducted to identify potential factors affecting statin prescriptions.
Results:
Our patient population was predominantly African American, representing more than 70% of our clinic patients. We found 87% of persons with ASCVD and 70% of persons with diabetes were on statin. We found no differences in statin prescriptions by demographic characteristics among persons with ASCVD. Among patients with diabetes, younger age (p<0.01), female sex (p<0.05), non-black race (p<0.05) and private insurance/lack of insurance (p<0.01) were associated with a lower likelihood of being prescribed a statin.
Conclusion:
Statin prescriptions among patients with ASCVD and diabetes appear to be higher in our patient population compared to prior national estimates, however statin prevalence remains suboptimal. Our next steps are to begin a targeted educational intervention for residents in the continuity clinic and ultimately demonstrate that resident driven intervention is an effective way to increase compliance with the guidelines.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract 112: Statin Utilization in the Outpatient Clinic of a University Based Residency Training Program
Description:
Background:
Current guidelines released in 2013 recommend statins for five specific patient groups including persons with clinical atherosclerotic cardiovascular disease (ASCVD) and diabetes.
National estimates of statin utilization in 2012 report statin use in persons with ASCVD at 58.
8% and 63.
5% among persons with diabetes.
A recent review also showed suboptimal statin prescription rates prior to 2013, with only 23% being prescribed a statin at goal dose.
Our goal was to assess statin prescriptions in a large resident run outpatient clinic and identify factors affecting statin prescriptions as potential targets for intervention to improve compliance with the guidelines.
Methods:
We obtained data from the medical record data warehouse of a primary care outpatient clinic within a large safety-net hospital from Jan–Dec 2015.
The clinic is predominantly run by internal medicine residents and supervised by general internal medicine attending physicians.
Patients with a diagnosis of ASCVD and diabetes were identified and electronic medical records abstraction was done to identify persons who were prescribed a statin (regardless of dose).
Bivariate analyses were conducted to identify potential factors affecting statin prescriptions.
Results:
Our patient population was predominantly African American, representing more than 70% of our clinic patients.
We found 87% of persons with ASCVD and 70% of persons with diabetes were on statin.
We found no differences in statin prescriptions by demographic characteristics among persons with ASCVD.
Among patients with diabetes, younger age (p<0.
01), female sex (p<0.
05), non-black race (p<0.
05) and private insurance/lack of insurance (p<0.
01) were associated with a lower likelihood of being prescribed a statin.
Conclusion:
Statin prescriptions among patients with ASCVD and diabetes appear to be higher in our patient population compared to prior national estimates, however statin prevalence remains suboptimal.
Our next steps are to begin a targeted educational intervention for residents in the continuity clinic and ultimately demonstrate that resident driven intervention is an effective way to increase compliance with the guidelines.
Related Results
Uudissanoja
Uudissanoja
Kielenaineksetajoittaa (kieli: suomi, sivulla: 112)alisteinen (kieli: suomi, sivulla: 112)emälaiva (kieli: suomi, sivulla: 113)emälippu (kieli: suomi, sivulla: 113)ennakoida (kieli...
Abstract P1-15-03: Assessing the association of statins with clinical outcomes in women with breast cancer
Abstract P1-15-03: Assessing the association of statins with clinical outcomes in women with breast cancer
Abstract
Background: A growing number of studies are claiming lipid-lowering medications (LLMs) primarily statins have anticancer properties to inhibit proliferation...
Predictors of statin adherence in primary care using real-world data
Predictors of statin adherence in primary care using real-world data
Abstract
Purpose
The objective of this study was to identify predictors of statin adherence in the primary and secondary preven...
Geographic Trends in the Ophthalmology Residency Match: Influence of Program and Applicant Characteristics
Geographic Trends in the Ophthalmology Residency Match: Influence of Program and Applicant Characteristics
Abstract
Introduction The ophthalmology residency match remains competitive. Several prior studies have examined various factors that contribute to a successful match int...
1228-P: Comparison between Combination of Low- or Moderate-Intensity Statin with Ezetimibe and High-Intensity Statin Monotherapy for Primary Prevention of Cardiovascular Disease and All-Cause Mortalities in Patients with Type 2 Diabetes—A Propensity-Match
1228-P: Comparison between Combination of Low- or Moderate-Intensity Statin with Ezetimibe and High-Intensity Statin Monotherapy for Primary Prevention of Cardiovascular Disease and All-Cause Mortalities in Patients with Type 2 Diabetes—A Propensity-Match
Background and Aims: Here, we compared the effects of combination therapy of low- or moderate-statin with ezetimibe and high-intensity statin monotherapy in patients with type 2 di...
Investigation of the Statin Paradox in Different Populations of VICs
Investigation of the Statin Paradox in Different Populations of VICs
Abstract
While numerous clinical studies have examined the effect of HMG-CoA reductase inhibitors (statin drugs) on calcific aortic valve disease (CAVD), their co...
Electronic health record (EHR)-detectable statin intolerance phenotypes: Prevalence and validation in real-world general practice
Electronic health record (EHR)-detectable statin intolerance phenotypes: Prevalence and validation in real-world general practice
ABSTRACT
Aims
This study focused on patients who were prescribed statins as primary prevention of cardiovascular diseases. This...
Statin use and the risk of Acute Myeloid Leukemia: A retrospective propensity-matched cohort study
Statin use and the risk of Acute Myeloid Leukemia: A retrospective propensity-matched cohort study
Abstract
Background: Statins, among the most widely prescribed medications worldwide, inhibit the mevalonate pathway and...

